On June 8, 2020 (BJT), Novel Peptide Bioscience Co., Ltd. was registered and incorporated in Banan District, Chongqing, and officially settled in Chongqing International Biological City.

Novel Peptide Bioscience Co., Ltd. has a complete new drug R&D system from conceptual design of new drugs, preclinical study, exploration of technical parameters of pharmaceuticals pilot and scale-up processes to clinical study. The Company has an R&D team dedicated to innovative products for active immunotherapy and a core team in charge of key aspects including company management, preclinical study and clinical study, production and sales. The President, when expressed his confidence in the platform in Chongqing International Biological City, said that its settlement in Chongqing International Biological City would enable Novel Peptide to develop rapidly by taking advantage of the platform policy.